85 related articles for article (PubMed ID: 24055409)
1. Trasferrin receptor 2 gene regulation by microRNA 221 in SH-SY5Y cells treated with MPP⁺ as Parkinson's disease cellular model.
Asci R; Vallefuoco F; Andolfo I; Bruno M; De Falco L; Iolascon A
Neurosci Res; 2013 Nov; 77(3):121-7. PubMed ID: 24055409
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-599 regulates the development of Parkinson's disease through mediating LRRK2 expression.
Wu Q; Xi DZ; Wang YH
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):724-731. PubMed ID: 30720180
[TBL] [Abstract][Full Text] [Related]
3. Transferrin receptor 2 is frequently expressed in human cancer cell lines.
Calzolari A; Oliviero I; Deaglio S; Mariani G; Biffoni M; Sposi NM; Malavasi F; Peschle C; Testa U
Blood Cells Mol Dis; 2007; 39(1):82-91. PubMed ID: 17428703
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of miR-200a and miR-204 in MPP
Talepoor Ardakani M; Rostamian Delavar M; Baghi M; Nasr-Esfahani MH; Kiani-Esfahani A; Ghaedi K
Mol Genet Genomic Med; 2019 Mar; 7(3):e548. PubMed ID: 30712312
[TBL] [Abstract][Full Text] [Related]
5. miR-29c-3p regulates TET2 expression and inhibits autophagy process in Parkinson's disease models.
Wang R; Yao J; Gong F; Chen S; He Y; Hu C; Li C
Genes Cells; 2021 Sep; 26(9):684-697. PubMed ID: 34086379
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of microRNA-505 suppressed MPP+ -induced cytotoxicity of SHSY5Y cells in an in vitro Parkinson's disease model.
Zhu J; Wang S; Liang Y; Xu X
Eur J Pharmacol; 2018 Sep; 835():11-18. PubMed ID: 30025813
[TBL] [Abstract][Full Text] [Related]
7. Targeted disruption of the hepatic transferrin receptor 2 gene in mice leads to iron overload.
Wallace DF; Summerville L; Subramaniam VN
Gastroenterology; 2007 Jan; 132(1):301-10. PubMed ID: 17241880
[TBL] [Abstract][Full Text] [Related]
8. TfR2 expression in human colon carcinomas.
Calzolari A; Deaglio S; Maldi E; Cassoni P; Malavasi F; Testa U
Blood Cells Mol Dis; 2009; 43(3):243-9. PubMed ID: 19729324
[TBL] [Abstract][Full Text] [Related]
9. Analyses for binding of the transferrin family of proteins to the transferrin receptor 2.
Kawabata H; Tong X; Kawanami T; Wano Y; Hirose Y; Sugai S; Koeffler HP
Br J Haematol; 2004 Nov; 127(4):464-73. PubMed ID: 15521925
[TBL] [Abstract][Full Text] [Related]
10. miR-494-3p modulates the progression of in vitro and in vivo Parkinson's disease models by targeting SIRT3.
Geng L; Zhang T; Liu W; Chen Y
Neurosci Lett; 2018 May; 675():23-30. PubMed ID: 29567426
[TBL] [Abstract][Full Text] [Related]
11. Effects of cell proliferation on the uptake of transferrin-bound iron by human hepatoma cells.
Lee AW; Oates PS; Trinder D
Hepatology; 2003 Oct; 38(4):967-77. PubMed ID: 14512884
[TBL] [Abstract][Full Text] [Related]
12. Iron absorption and hepatic iron uptake are increased in a transferrin receptor 2 (Y245X) mutant mouse model of hemochromatosis type 3.
Drake SF; Morgan EH; Herbison CE; Delima R; Graham RM; Chua AC; Leedman PJ; Fleming RE; Bacon BR; Olynyk JK; Trinder D
Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G323-8. PubMed ID: 16935854
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling of MPP+-treated MN9D cells: a mechanism of toxicity study.
Wang J; Xu Z; Fang H; Duhart HM; Patterson TA; Ali SF
Neurotoxicology; 2007 Sep; 28(5):979-87. PubMed ID: 17475336
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of mixed lineage kinase 3 attenuates MPP+-induced neurotoxicity in SH-SY5Y cells.
Mathiasen JR; McKenna BA; Saporito MS; Ghadge GD; Roos RP; Holskin BP; Wu ZL; Trusko SP; Connors TC; Maroney AC; Thomas BA; Thomas JC; Bozyczko-Coyne D
Brain Res; 2004 Apr; 1003(1-2):86-97. PubMed ID: 15019567
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-409-3p Targeting at ATXN3 Reduces the Apoptosis of Dopamine Neurons Based on the Profile of miRNAs in the Cerebrospinal Fluid of Early Parkinson's Disease.
Tan X; Hu J; Ming F; Lv L; Yan W; Peng X; Bai R; Xiao Q; Zhang H; Tang B; Wang C; Tan J
Front Cell Dev Biol; 2021; 9():755254. PubMed ID: 35111747
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Epidermal Growth Factor Receptor Related Gene Expression Changes in a Cellular and Animal Model of Parkinson's Disease.
Kim IS; Koppula S; Park SY; Choi DK
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28212331
[TBL] [Abstract][Full Text] [Related]
17. Regulation of transferrin receptor 2 in human cancer cell lines.
Calzolari A; Finisguerra V; Oliviero I; Deaglio S; Mariani G; Malavasi F; Testa U
Blood Cells Mol Dis; 2009; 42(1):5-13. PubMed ID: 19019709
[TBL] [Abstract][Full Text] [Related]
18. Manganese exposure: Linking down-regulation of miRNA-7 and miRNA-433 with α-synuclein overexpression and risk of idiopathic Parkinson's disease.
Tarale P; Daiwile AP; Sivanesan S; Stöger R; Bafana A; Naoghare PK; Parmar D; Chakrabarti T; Krishnamurthi K
Toxicol In Vitro; 2018 Feb; 46():94-101. PubMed ID: 28986288
[TBL] [Abstract][Full Text] [Related]
19. Similar potency of catechin and its enantiomers in alleviating 1-methyl-4-phenylpyridinium ion cytotoxicity in SH-SY5Y cells.
Ruan HL; Yang Y; Zhu XN; Wang XL; Chen RZ
J Pharm Pharmacol; 2011 Sep; 63(9):1169-74. PubMed ID: 21827489
[TBL] [Abstract][Full Text] [Related]
20. SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease.
Xie HR; Hu LS; Li GY
Chin Med J (Engl); 2010 Apr; 123(8):1086-92. PubMed ID: 20497720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
